elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
0008-5472.CAN-07-1872
0008-5472.CAN-07-1872
http://dx.doi.org/10.1158/0008-5472.CAN-07-1872
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan
P356
Q24328949-92453DDB-5A08-4CCF-9EF5-1970AA8F374D
P356
0008-5472.CAN-07-1872
http://dx.doi.org/10.1158/0008-5472.CAN-07-1872